PDE-Glo™ Phosphodiesterase Assay Technical Bulletin
Instructions for Use of Product(s)
V1361
Literature # TB353
The PDE-Glo™ Phosphodiesterase Assay is a luminescent, high-throughput screening method for measuring cyclic nucleotide phosphodiesterase (PDE) activity from purified sources. PDEs have been implicated in a variety of diseases such as erectile dysfunction, asthma, chronic obstructive pulmonary disease, learning disorders, depression and memory functions, neurodegenerative diseases, autoimmune disorders, heart failure and myocardial infarction. The availability of selective inhibitors for PDEs has facilitated their use as tools to study cyclic nucleotide signaling and paved the way to investigate the role of PDEs in cellular and tissue pathologies. The PDE-Glo™ Phosphodiesterase Assay allows lead candidates for PDE inhibitors to be identified.
Summary of Changes
The following changes were made to the 6/21 revision of this document:
1. Removed the discontinued Cat.# V1362.
2. Revised Section 6.B.
3. Updated the cover page.
Revised 6/21.